Skip to main content

Table 4 Use of secondary prevention medications at the time of "MI admission" in RA and control patients with a prior history of MI

From: Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population

 

RA (n= 10)

Controls (n= 11)

Aspirin, n (%)

3 (30)

6 (55)

Beta blocker, n (%)

1 (10)

4 (36)

ACE inhibitor, n (%)

3 (30)

3 (27)

Lipid-lowering agent, n (%)

2 (20)

5 (45)

  1. ACE, angiotensin-converting enzyme; RA, rheumatoid arthritis.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us